Gera J - Search Results

1

Specific blockade of Rictor-mTOR association inhibits mTORC2 activity and is cytotoxic in glioblastoma.

Benavides-Serrato A, Lee J, Holmes B, Landon KA, Bashir T, Jung ME, Lichtenstein A, Gera J. Benavides-Serrato A, et al. Among authors: gera j. PLoS One. 2017 Apr 28;12(4):e0176599. doi: 10.1371/journal.pone.0176599. eCollection 2017. PLoS One. 2017. Retraction in: PLoS One. 2023 Sep 8;18(9):e0291490. doi: 10.1371/journal.pone.0291490 PMID: 28453552 Free PMC article. Retracted.

2

Human neutrophil peptide defensins induce single strand DNA breaks in target cells.

Gera JF, Lichtenstein A. Gera JF, et al. Cell Immunol. 1991 Nov;138(1):108-20. doi: 10.1016/0008-8749(91)90136-y. Cell Immunol. 1991. PMID: 1913832

3

Inhibition of DNA repair with aphidicolin enhances sensitivity of targets to tumor necrosis factor.

Gera JF, Fady C, Gardner A, Jacoby FJ, Briskin KB, Lichtenstein A. Gera JF, et al. J Immunol. 1993 Oct 1;151(7):3746-57. J Immunol. 1993. PMID: 8376804

4

Signal pathways involved in activation of p70S6K and phosphorylation of 4E-BP1 following exposure of multiple myeloma tumor cells to interleukin-6.

Shi Y, Hsu JH, Hu L, Gera J, Lichtenstein A. Shi Y, et al. Among authors: gera j. J Biol Chem. 2002 May 3;277(18):15712-20. doi: 10.1074/jbc.M200043200. Epub 2002 Feb 28. J Biol Chem. 2002. PMID: 11872747 Free article.

5

Enhanced sensitivity of multiple myeloma cells containing PTEN mutations to CCI-779.

Shi Y, Gera J, Hu L, Hsu JH, Bookstein R, Li W, Lichtenstein A. Shi Y, et al. Among authors: gera j. Cancer Res. 2002 Sep 1;62(17):5027-34. Cancer Res. 2002. PMID: 12208757

6

Downstream effectors of oncogenic ras in multiple myeloma cells.

Hu L, Shi Y, Hsu JH, Gera J, Van Ness B, Lichtenstein A. Hu L, et al. Among authors: gera j. Blood. 2003 Apr 15;101(8):3126-35. doi: 10.1182/blood-2002-08-2640. Epub 2002 Dec 19. Blood. 2003. PMID: 12515720 Free article.

7

Cytoreductive effects of farnesyl transferase inhibitors on multiple myeloma tumor cells.

Shi Y, Gera J, Hsu JH, Van Ness B, Lichtenstein A. Shi Y, et al. Among authors: gera j. Mol Cancer Ther. 2003 Jun;2(6):563-72. Mol Cancer Ther. 2003. PMID: 12813136

8

AKT activity determines sensitivity to mammalian target of rapamycin (mTOR) inhibitors by regulating cyclin D1 and c-myc expression.

Gera JF, Mellinghoff IK, Shi Y, Rettig MB, Tran C, Hsu JH, Sawyers CL, Lichtenstein AK. Gera JF, et al. J Biol Chem. 2004 Jan 23;279(4):2737-46. doi: 10.1074/jbc.M309999200. Epub 2003 Oct 23. J Biol Chem. 2004. PMID: 14576155 Free article.

9

Interleukin-6 activates phosphoinositol-3' kinase in multiple myeloma tumor cells by signaling through RAS-dependent and, separately, through p85-dependent pathways.

Hsu JH, Shi Y, Frost P, Yan H, Hoang B, Sharma S, Gera J, Lichtenstein A. Hsu JH, et al. Among authors: gera j. Oncogene. 2004 Apr 22;23(19):3368-75. doi: 10.1038/sj.onc.1207459. Oncogene. 2004. PMID: 15021914

10

In vivo antitumor effects of the mTOR inhibitor CCI-779 against human multiple myeloma cells in a xenograft model.

Frost P, Moatamed F, Hoang B, Shi Y, Gera J, Yan H, Frost P, Gibbons J, Lichtenstein A. Frost P, et al. Among authors: gera j. Blood. 2004 Dec 15;104(13):4181-7. doi: 10.1182/blood-2004-03-1153. Epub 2004 Aug 10. Blood. 2004. PMID: 15304393 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

89 results

Search Page

Filters